4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001296549-26-000002
Options or other derivatives
- Director acquired 1,192,946 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Belldegrun Arie Director | 2026-02-02 | Grant or award · Stock Option (Right to buy) | +929,913 | 929,913 | D: show line 1 in the form | |||||
| Belldegrun Arie Director | 2026-02-02 | Grant or award · Restricted Stock Unit | +263,033 | 263,033 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1770242650.xml…